UBS Group’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Sell |
170,982
-72,914
| -30% | -$956K | ﹤0.01% | 3733 |
|
|
2025
Q1 | $5.37M | Buy |
243,896
+151,830
| +165% | +$3.34M | ﹤0.01% | 2911 |
|
|
2024
Q4 | $2.46M | Buy |
92,066
+16,761
| +22% | +$448K | ﹤0.01% | 3560 |
|
|
2024
Q3 | $2.01M | Buy |
75,305
+14,795
| +24% | +$395K | ﹤0.01% | 3018 |
|
|
2024
Q2 | $1.09M | Sell |
60,510
-13,608
| -18% | -$245K | ﹤0.01% | 3331 |
|
|
2024
Q1 | $1.35M | Buy |
+74,118
| New | +$1.35M | ﹤0.01% | 3325 |
|
|
2023
Q1 | – | Sell |
-1,551
| Closed | -$13.9K | – | 8603 |
|
|
2022
Q4 | $13.9K | Buy |
+1,551
| New | +$13.9K | ﹤0.01% | 6938 |
|
|
2022
Q2 | – | Sell |
-22,047
| Closed | -$214K | – | 9366 |
|
|
2022
Q1 | $214K | Buy |
+22,047
| New | +$214K | ﹤0.01% | 4319 |
|
|
2021
Q3 | – | Sell |
-868
| Closed | -$19K | – | 8463 |
|
|
2021
Q2 | $19K | Buy |
+868
| New | +$19K | ﹤0.01% | 6288 |
|